Review: Inhaled insulin provides better glycemic control than oral hypoglycemic agents but not better than subcutaneous insulin

摘要

As the arsenal of antidiabetes medications expands, insulin remains thenmost potent glucose-lowering agent available and is the only one forntype 1 diabetes. Despite the large proportion of diabetic patients withnsuboptimally controlled blood sugar, relatively few take insulin (1), innpart because of the perceived difficulty and pain of parenteral administration.nInhalation of insulin, if safe and efficacious, may be a morenacceptable alternative to SC injection.